Document is current
Any future updates will be listed below
-
Authors
Takeda, Yuichiro
Naka, Go
Katsuya, Yuki
Kobayashi, Konomi
Suzuki, Manabu
Hashimoto, Masao
Hirano, Satoshi
Uemura, Yukari
-
Funding
Funding for this research was provided by:
the National Center of Global Health and Medicine Intramural Research Fund (29A2017, 29A2017, 29A2017)
- License Information
-
More Information
Article History
Received: 6 March 2023
Accepted: 4 August 2023
First Online: 26 August 2023
Declarations
:
: The study was conducted following the principles of the Declaration of Helsinki. The study protocol was approved by the institutional ethics committees of the National Center for Global Health and Medicine (NCGM-G-001274–04 and NCGM-G-0000188–03). Patients provided written informed consent.
: Not applicable.
: YT reports grants from Chugai and Boehringer Ingelheim and personal fees from MSD, Ono Pharmaceutical, and Otsuka Pharmaceutical Co. Ltd. outside the submitted work. GN reports personal fees from Astra Zeneca, Chugai Pharmaceutical, and Ono Pharmaceutical outside of the submitted work. KK reports personal fees (lecture fees) from MSD, Chugai, AstraZeneca, and Taiho Pharmaceutical Co. Ltd., outside the submitted work. YU reports personal fees from Chugai Pharmaceutical and Lilly outside of the submitted work. YK, MS, MH, and SH declare no conflicts of interest.
